Researchers from the cancer pharmacy team presented posters of their work at the recent BOPA Conference. The work was produced by the Academic Pharmacy Practice Unit, a joint collaboration between pharmacy practice at Reading and Oxford University Hospitals.
The first poster by Wilcock, E. Barnett, N. Donyai, P. and Stoner N. presented work from a study which was conducted to assess the feasibility of using health coaching sessions with cancer patients recieving oral anticancer therapy. The second poster presented by Yau, J. Grant, D and Stoner, N reported the implementation of Talimogene laherparepvec (T-VEC), a gene therapy for unresectable metastatic melanoma, in NHS Trusts across the UK.